8RAR
Crystal structure of chimeric human carbonic anhydrase IX with N-butyl-4-chloro-2-(cyclohexylsulfanyl)-5-sulfamoylbenzamide
8RAR の概要
エントリーDOI | 10.2210/pdb8rar/pdb |
分子名称 | Carbonic anhydrase 2, ZINC ION, ~{N}-butyl-4-chloranyl-2-cyclohexylsulfanyl-5-sulfamoyl-benzamide, ... (5 entities in total) |
機能のキーワード | drug design, carbonic anhydrase, benzenesulfonamide, lyase-lyase inhibitor complex, lyase |
由来する生物種 | Homo sapiens (human) |
タンパク質・核酸の鎖数 | 1 |
化学式量合計 | 29791.51 |
構造登録者 | |
主引用文献 | Paketuryte-Latve, V.,Smirnov, A.,Manakova, E.,Baranauskiene, L.,Petrauskas, V.,Zubriene, A.,Matuliene, J.,Dudutiene, V.,Capkauskaite, E.,Zaksauskas, A.,Leitans, J.,Grazulis, S.,Tars, K.,Matulis, D. From X-ray crystallographic structure to intrinsic thermodynamics of protein-ligand binding using carbonic anhydrase isozymes as a model system. Iucrj, 11:556-569, 2024 Cited by PubMed Abstract: Carbonic anhydrase (CA) was among the first proteins whose X-ray crystal structure was solved to atomic resolution. CA proteins have essentially the same fold and similar active centers that differ in only several amino acids. Primary sulfonamides are well defined, strong and specific binders of CA. However, minor variations in chemical structure can significantly alter their binding properties. Over 1000 sulfonamides have been designed, synthesized and evaluated to understand the correlations between the structure and thermodynamics of their binding to the human CA isozyme family. Compound binding was determined by several binding assays: fluorescence-based thermal shift assay, stopped-flow enzyme activity inhibition assay, isothermal titration calorimetry and competition assay for enzyme expressed on cancer cell surfaces. All assays have advantages and limitations but are necessary for deeper characterization of these protein-ligand interactions. Here, the concept and importance of intrinsic binding thermodynamics is emphasized and the role of structure-thermodynamics correlations for the novel inhibitors of CA IX is discussed - an isozyme that is overexpressed in solid hypoxic tumors, and thus these inhibitors may serve as anticancer drugs. The abundant structural and thermodynamic data are assembled into the Protein-Ligand Binding Database to understand general protein-ligand recognition principles that could be used in drug discovery. PubMed: 38856178DOI: 10.1107/S2052252524004627 主引用文献が同じPDBエントリー |
実験手法 | X-RAY DIFFRACTION (1.15 Å) |
構造検証レポート
検証レポート(詳細版)
をダウンロード
